Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study-Reference-Cited by-同舟云学术

Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study

Published:2019-06 Issue: Volume:7 Page:75-81
ISSN:2405-8521
Container-title:Papillomavirus Research
language:en
Short-container-title:Papillomavirus Research

Author:

Basu Partha,Muwonge Richard,Bhatla Neerja,Nene Bhagwan M.,Joshi Smita,Esmy Pulikottil O.,Poli Usha Rani Reddy,Joshi Geeta,Verma Yogesh,Zomawia Eric,Shastri Surendra S.,Pimple Sharmila,Anantharaman Devasena,Prabhu Priya R.,Hingmire Sanjay,Sauvaget Catherine^ORCID,Lucas Eric,Pawlita Michael^ORCID,Gheit Tarik^ORCID,Jayant Kasturi,Malvi Sylla G.,Siddiqi Maqsood,Michel Angelika,Butt Julia,Sankaran Subha,Rameshwari Ammal Kannan Thiraviam Pillai,Varghese Rintu,Divate Uma,Willhauck-Fleckenstein Martina,Waterboer Tim,Müller Martin,Sehr Peter,Vashist Shachi,Mishra Gauravi,Jadhav Radhika,Thorat Ranjit,Tommasino Massimo,Pillai M. Radhakrishna,Sankaranarayanan Rengaswamy

Funder

Bill & Melinda Gates Foundation

European Commission Seventh Framework Programme

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference15 articles.

1. Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 – conclusions and recommendations;World Health Organization,2014

2. World Health Organization, Primary end-points for prophylactic HPV vaccine trials. IARC Working Group Report, Volume 7, IARC, Lyon, 2014.

3. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial;Dobson;J. Am. Med. Assoc.,2013

4. HPV Vaccines: Systematic Review of Literature on Alternative Vaccination Schedules;D’Addario,2014

5. World Health Organization. Immunization in a Changing World leadership, population growth, migration, emerging diseases, polio transition. IVB Director’s report to SAGE − 17 April 2018. Available from: 〈http://www.who.int/immunization/sage/meetings/2018/april/1_SAGE_April_2018-Directors_Report-Martin_Friede.pdf?Ua=1〉 (accessed on 8 November 2018).

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cervical cancer advocacy: needs more than faking death;The Lancet Regional Health - Southeast Asia;2024-06

2. Immunogenicity of quadrivalent human papillomavirus vaccine among Alaska Native children aged 9–14 years at 5 years after vaccination;Vaccine;2024-05

3. ‘I was able to make a better decision about my health.’ Wāhine experiences of colposcopy at a marae‐based health clinic: A qualitative study;Australian and New Zealand Journal of Obstetrics and Gynaecology;2024-02-29

4. Impact of HPV vaccination on HPV-related oral infections;Oral Oncology;2023-01

5. Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources;Expert Review of Vaccines;2021-12-13